Hui Lyu
The Fourth People's Hospital of Zibo City(CN)State Nuclear Power Technology Company (China)(CN)Central Hospital of Zibo(CN)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Histone Deacetylase Inhibitors Research, Cancer-related Molecular Pathways, RNA modifications and cancer
Most-Cited Works
- → Targeting of erbB3 receptor to overcome resistance in cancer treatment(2014)181 cited
- → Understanding the biology of HER3 receptor as a therapeutic target in human cancer(2018)125 cited
- → Downregulation of the long noncoding RNA GAS5-AS1 contributes to tumor metastasis in non-small cell lung cancer(2016)115 cited
- → ALKBH5-Mediated m6A Demethylation of GLUT4 mRNA Promotes Glycolysis and Resistance to HER2-Targeted Therapy in Breast Cancer(2022)101 cited
- MicroRNA regulation and therapeutic targeting of survivin in cancer.(2015)
- → Disruption of FOXO3a-miRNA feedback inhibition of IGF2/IGF-1R/IRS1 signaling confers Herceptin resistance in HER2-positive breast cancer(2021)83 cited
- → Development of Effective Therapeutics Targeting HER3 for Cancer Treatment(2019)81 cited